Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,139.60
(
0.52%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
100.65
(
2.39%
)
Bitcoin
74,400.02
(
-0.59%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: DewDiligence post# 109010

Sunday, 11/28/2010 7:28:57 AM

Sunday, November 28, 2010 7:28:57 AM

Post# of 257253

Portola is targeting the same Lovenox-reversal market as PYMX,
although Portola’s program is still in preclinical development.




Portola's drug is a next generation FXa Inhibitor antidote as opposed to PYMX's drug which reverses Heparin and LMWH. Does Portola claim their drug will also reverse Heparin/LMWH?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now